189,422 Shares in Cronos Group Inc. $CRON Purchased by Nuveen LLC

Key Points

• Nuveen LLC acquired a new stake in Cronos Group Inc. by purchasing 189,422 shares, valued at approximately $341,000.
• Recent trading data shows Cronos Group's stock price is currently at $2.50, with a 52-week low of $1.60 and a high of $2.77.
• Cronos Group reported a loss of ($0.10) EPS for the most recent quarter, missing analyst expectations, while revenue was reported at $33.46 million.

Nuveen LLC acquired a new stake in Cronos Group Inc. (NASDAQ:CRON - Free Report) during the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm acquired 189,422 shares of the company's stock, valued at approximately $341,000.

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Aigen Investment Management LP purchased a new position in Cronos Group in the 1st quarter valued at $35,000. MMCAP International Inc. SPC lifted its holdings in Cronos Group by 2.9% in the 1st quarter. MMCAP International Inc. SPC now owns 1,786,382 shares of the company's stock valued at $3,233,000 after purchasing an additional 49,782 shares in the last quarter. Connor Clark & Lunn Investment Management Ltd. lifted its holdings in Cronos Group by 53.7% in the 1st quarter. Connor Clark & Lunn Investment Management Ltd. now owns 47,800 shares of the company's stock valued at $86,000 after purchasing an additional 16,700 shares in the last quarter. SeaCrest Wealth Management LLC lifted its holdings in Cronos Group by 66.0% in the 1st quarter. SeaCrest Wealth Management LLC now owns 314,100 shares of the company's stock valued at $569,000 after purchasing an additional 124,855 shares in the last quarter. Finally, Formidable Asset Management LLC lifted its holdings in Cronos Group by 2.1% in the 4th quarter. Formidable Asset Management LLC now owns 278,398 shares of the company's stock valued at $562,000 after purchasing an additional 5,637 shares in the last quarter. Hedge funds and other institutional investors own 8.71% of the company's stock.

Cronos Group Stock Up 0.6%

Shares of CRON traded up $0.02 during midday trading on Thursday, reaching $2.55. The company had a trading volume of 180,786 shares, compared to its average volume of 1,914,777. Cronos Group Inc. has a 1-year low of $1.60 and a 1-year high of $2.77. The stock has a market cap of $974.46 million, a PE ratio of 50.90 and a beta of 1.13. The firm has a 50 day simple moving average of $2.28 and a 200-day simple moving average of $2.03.

Cronos Group (NASDAQ:CRON - Get Free Report) last issued its quarterly earnings data on Thursday, August 7th. The company reported ($0.10) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.02) by ($0.08). The business had revenue of $33.46 million for the quarter, compared to analyst estimates of $45.73 million. Cronos Group had a negative return on equity of 3.78% and a net margin of 14.19%. As a group, sell-side analysts anticipate that Cronos Group Inc. will post -0.03 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

Separately, Wall Street Zen upgraded Cronos Group from a "sell" rating to a "hold" rating in a report on Saturday, August 30th.

About Cronos Group

Cronos Group Inc operates as a cannabinoid company that engages in the cultivation, production and marketing of cannabis products in Canada, Israel, and Germany. It offers dried flower, pre-rolls, oils, vaporizers, edibles, and cannabis tinctures under the Spinach, Lord Jones, and PEACE NATURALS brands.